pd-l1 biomarker Search Results


pd-l1 + tils  (CH Instruments)
90
CH Instruments pd-l1 + tils
Flow cytometric analysis for the phenotypes and TCR-Vβ of TILs and matched PBMCs. a Helper (CD4+) and cytotoxic (CD8+) T-cell subsets in TILs and matched PBMCs; b CD4+ /CD8+ T-cell ratio; c, d naïve (CD45RA+ CD45RO−) and antigen-experienced (CD45RA− CD45RO+) population within CD4+ /CD8+ T-cell subsets; e–h T cells displaying exhausted phenotypes (PD-1+ and Tim-3+) within CD4 + /CD8 + subsets and antigen-experienced T cells (CD45RA-CD45RO+); i Th17 (CD4+ IL-17A+), Tc17 (CD8+ IL17A+), CD4+ Tregs (CD4+ CD25+ Foxp3+), CD8+ Tregs (CD8+ CD25+ Foxp3+), and Th17/Treg ratio in CD4+ T cell; j Th17/Th1(IL-17A+ IFN-γ+) and Th17/Th2 population (IL17A+ IL4+) within CD4 + T cell; k antigen-experienced B cells (CD19+ CD27+), plasma cells (CD19+ <t>CD138+),</t> regulatory B cell (CD19+ IL-10+), and plasmablasts (CD19+ CD38+); l, m TCR-Vβ repertoire in CD4+ /CD8+ T cells. All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 was considered significant; NS not significant
Pd L1 + Tils, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-l1+biomarker/pd+l1+biomarker/pmc11027813-221-8-20
Average 90 stars, based on 1 article reviews
pd-l1 + tils - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pd-l1 biomarkers  (NanoView Biosciences)
90
NanoView Biosciences pd-l1 biomarkers
Flow cytometric analysis for the phenotypes and TCR-Vβ of TILs and matched PBMCs. a Helper (CD4+) and cytotoxic (CD8+) T-cell subsets in TILs and matched PBMCs; b CD4+ /CD8+ T-cell ratio; c, d naïve (CD45RA+ CD45RO−) and antigen-experienced (CD45RA− CD45RO+) population within CD4+ /CD8+ T-cell subsets; e–h T cells displaying exhausted phenotypes (PD-1+ and Tim-3+) within CD4 + /CD8 + subsets and antigen-experienced T cells (CD45RA-CD45RO+); i Th17 (CD4+ IL-17A+), Tc17 (CD8+ IL17A+), CD4+ Tregs (CD4+ CD25+ Foxp3+), CD8+ Tregs (CD8+ CD25+ Foxp3+), and Th17/Treg ratio in CD4+ T cell; j Th17/Th1(IL-17A+ IFN-γ+) and Th17/Th2 population (IL17A+ IL4+) within CD4 + T cell; k antigen-experienced B cells (CD19+ CD27+), plasma cells (CD19+ <t>CD138+),</t> regulatory B cell (CD19+ IL-10+), and plasmablasts (CD19+ CD38+); l, m TCR-Vβ repertoire in CD4+ /CD8+ T cells. All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 was considered significant; NS not significant
Pd L1 Biomarkers, supplied by NanoView Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-l1+biomarker/pd+l1+biomarkers/pmc07480431-5218-71-55
Average 90 stars, based on 1 article reviews
pd-l1 biomarkers - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pd-l1 biomarker  (MBL Life science)
90
MBL Life science pd-l1 biomarker
Flow cytometric analysis for the phenotypes and TCR-Vβ of TILs and matched PBMCs. a Helper (CD4+) and cytotoxic (CD8+) T-cell subsets in TILs and matched PBMCs; b CD4+ /CD8+ T-cell ratio; c, d naïve (CD45RA+ CD45RO−) and antigen-experienced (CD45RA− CD45RO+) population within CD4+ /CD8+ T-cell subsets; e–h T cells displaying exhausted phenotypes (PD-1+ and Tim-3+) within CD4 + /CD8 + subsets and antigen-experienced T cells (CD45RA-CD45RO+); i Th17 (CD4+ IL-17A+), Tc17 (CD8+ IL17A+), CD4+ Tregs (CD4+ CD25+ Foxp3+), CD8+ Tregs (CD8+ CD25+ Foxp3+), and Th17/Treg ratio in CD4+ T cell; j Th17/Th1(IL-17A+ IFN-γ+) and Th17/Th2 population (IL17A+ IL4+) within CD4 + T cell; k antigen-experienced B cells (CD19+ CD27+), plasma cells (CD19+ <t>CD138+),</t> regulatory B cell (CD19+ IL-10+), and plasmablasts (CD19+ CD38+); l, m TCR-Vβ repertoire in CD4+ /CD8+ T cells. All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 was considered significant; NS not significant
Pd L1 Biomarker, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pd-l1+biomarker/pd+l1+biomarker/pm29730815-117-7-15
Average 90 stars, based on 1 article reviews
pd-l1 biomarker - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Flow cytometric analysis for the phenotypes and TCR-Vβ of TILs and matched PBMCs. a Helper (CD4+) and cytotoxic (CD8+) T-cell subsets in TILs and matched PBMCs; b CD4+ /CD8+ T-cell ratio; c, d naïve (CD45RA+ CD45RO−) and antigen-experienced (CD45RA− CD45RO+) population within CD4+ /CD8+ T-cell subsets; e–h T cells displaying exhausted phenotypes (PD-1+ and Tim-3+) within CD4 + /CD8 + subsets and antigen-experienced T cells (CD45RA-CD45RO+); i Th17 (CD4+ IL-17A+), Tc17 (CD8+ IL17A+), CD4+ Tregs (CD4+ CD25+ Foxp3+), CD8+ Tregs (CD8+ CD25+ Foxp3+), and Th17/Treg ratio in CD4+ T cell; j Th17/Th1(IL-17A+ IFN-γ+) and Th17/Th2 population (IL17A+ IL4+) within CD4 + T cell; k antigen-experienced B cells (CD19+ CD27+), plasma cells (CD19+ CD138+), regulatory B cell (CD19+ IL-10+), and plasmablasts (CD19+ CD38+); l, m TCR-Vβ repertoire in CD4+ /CD8+ T cells. All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 was considered significant; NS not significant

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

doi: 10.1007/s00262-020-02479-x

Figure Lengend Snippet: Flow cytometric analysis for the phenotypes and TCR-Vβ of TILs and matched PBMCs. a Helper (CD4+) and cytotoxic (CD8+) T-cell subsets in TILs and matched PBMCs; b CD4+ /CD8+ T-cell ratio; c, d naïve (CD45RA+ CD45RO−) and antigen-experienced (CD45RA− CD45RO+) population within CD4+ /CD8+ T-cell subsets; e–h T cells displaying exhausted phenotypes (PD-1+ and Tim-3+) within CD4 + /CD8 + subsets and antigen-experienced T cells (CD45RA-CD45RO+); i Th17 (CD4+ IL-17A+), Tc17 (CD8+ IL17A+), CD4+ Tregs (CD4+ CD25+ Foxp3+), CD8+ Tregs (CD8+ CD25+ Foxp3+), and Th17/Treg ratio in CD4+ T cell; j Th17/Th1(IL-17A+ IFN-γ+) and Th17/Th2 population (IL17A+ IL4+) within CD4 + T cell; k antigen-experienced B cells (CD19+ CD27+), plasma cells (CD19+ CD138+), regulatory B cell (CD19+ IL-10+), and plasmablasts (CD19+ CD38+); l, m TCR-Vβ repertoire in CD4+ /CD8+ T cells. All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 was considered significant; NS not significant

Article Snippet: By contrast, the number of PD-L1 + and CD138 + TILs was higher in large tumors than in small tumors (Chi-square test, Fig. f, i); higher expression levels of Foxp3+ and CD138+ TIL were positively associated with poor prognosis (Chi-square test, Fig. g, h).

Techniques: Clinical Proteomics

Correlation between TIL infiltration status and clinicopathologic features. a Mean counts of tumor-infiltrating lymphocytes. The CD8+ subpopulation was larger than the CD4+ subpopulation within infiltrated T cells, but the difference was not significant (Student’s t test). b The infiltrates of T cells were significantly more abundant than those of B cells in tumors (Student’s t test). c IL-17 was highly expressed in betel nut chewers. d CD20 was abundantly expressed in non-alcoholic patients. e IL-17 expression was significantly higher in smaller tumors (T1 + T2). f PD-L1 expression was significantly higher in lager tumors (T3 + T4). g High expression of Foxp3 + was positively associated with clinical stage. h High expression of CD138 was positively associated with clinical stage. i CD138 expression was significantly higher in larger tumors (T3 + T4). All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 as measured by the Chi-square test was considered significant

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

doi: 10.1007/s00262-020-02479-x

Figure Lengend Snippet: Correlation between TIL infiltration status and clinicopathologic features. a Mean counts of tumor-infiltrating lymphocytes. The CD8+ subpopulation was larger than the CD4+ subpopulation within infiltrated T cells, but the difference was not significant (Student’s t test). b The infiltrates of T cells were significantly more abundant than those of B cells in tumors (Student’s t test). c IL-17 was highly expressed in betel nut chewers. d CD20 was abundantly expressed in non-alcoholic patients. e IL-17 expression was significantly higher in smaller tumors (T1 + T2). f PD-L1 expression was significantly higher in lager tumors (T3 + T4). g High expression of Foxp3 + was positively associated with clinical stage. h High expression of CD138 was positively associated with clinical stage. i CD138 expression was significantly higher in larger tumors (T3 + T4). All error bars indicate SEM. 0.01 ≤ *p < 0.05, 0.001 ≤ **p < 0.01, ***p < 0.001. p < 0.05 as measured by the Chi-square test was considered significant

Article Snippet: By contrast, the number of PD-L1 + and CD138 + TILs was higher in large tumors than in small tumors (Chi-square test, Fig. f, i); higher expression levels of Foxp3+ and CD138+ TIL were positively associated with poor prognosis (Chi-square test, Fig. g, h).

Techniques: Expressing

IHC analysis of immune cell distribution within the microenvironment of OSCC. Considerable infiltration of lymphocytes within the microenvironment of OSCC. The majority of lymphocytes were distributed surrounding the tumor islands as compact clusters. Some were distributed sparsely or infiltrated into tumor islands. a, b Representative images of IHC for high and low CD4 expression; c, d CD8 expression; e, f CD20 expression; g, h PD-L1expression; i, j CD138 expression; k, l IL-17 expression; m, n Foxp3 expression; and o, p PD-1 expression; a, c, e, g, i, k, m, o high expression; b, d, f, h, j, l, n, p low expression; bars: 100 μm

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

doi: 10.1007/s00262-020-02479-x

Figure Lengend Snippet: IHC analysis of immune cell distribution within the microenvironment of OSCC. Considerable infiltration of lymphocytes within the microenvironment of OSCC. The majority of lymphocytes were distributed surrounding the tumor islands as compact clusters. Some were distributed sparsely or infiltrated into tumor islands. a, b Representative images of IHC for high and low CD4 expression; c, d CD8 expression; e, f CD20 expression; g, h PD-L1expression; i, j CD138 expression; k, l IL-17 expression; m, n Foxp3 expression; and o, p PD-1 expression; a, c, e, g, i, k, m, o high expression; b, d, f, h, j, l, n, p low expression; bars: 100 μm

Article Snippet: By contrast, the number of PD-L1 + and CD138 + TILs was higher in large tumors than in small tumors (Chi-square test, Fig. f, i); higher expression levels of Foxp3+ and CD138+ TIL were positively associated with poor prognosis (Chi-square test, Fig. g, h).

Techniques: Expressing

Prognostic value of TILs analyzed by a multivariate Cox regression model

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

doi: 10.1007/s00262-020-02479-x

Figure Lengend Snippet: Prognostic value of TILs analyzed by a multivariate Cox regression model

Article Snippet: By contrast, the number of PD-L1 + and CD138 + TILs was higher in large tumors than in small tumors (Chi-square test, Fig. f, i); higher expression levels of Foxp3+ and CD138+ TIL were positively associated with poor prognosis (Chi-square test, Fig. g, h).

Techniques:

Summary of the OS predictive accuracy of immune cells

Journal: Cancer Immunology, Immunotherapy : CII

Article Title: The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

doi: 10.1007/s00262-020-02479-x

Figure Lengend Snippet: Summary of the OS predictive accuracy of immune cells

Article Snippet: By contrast, the number of PD-L1 + and CD138 + TILs was higher in large tumors than in small tumors (Chi-square test, Fig. f, i); higher expression levels of Foxp3+ and CD138+ TIL were positively associated with poor prognosis (Chi-square test, Fig. g, h).

Techniques: